Scientific profile

  • About department
  • Employees
  • Laboratories

Our research focuses on three areas: the reward system of the brain, the molecular mechanisms of drug action, and neuro-pharmacogenomics.

The reward system of the brain encompasses all brain areas involved in reward-driven behaviors, with the mesolimbic dopamine system at the core. We have been studying the mechanisms involved in the plasticity of dopaminergic and dopaminoceptive neurons, and also the role of endogenous opioids in signaling rewards.

As the name of the Department implies a large part of our research focuses on the cellular and the molecular mechanisms of actions of psychotropic drugs, also with an emphasis on opioids. We hope that elucidating molecular signatures of drug action will lead to the identification of mechanisms essential for their therapeutic effects.

In recent years we have also been involved in neuro-pharmacogenomics, searching for associations between genetic background, neuropsychiatric disorders, and the effectiveness of pharmacotherapy. We use next-generation sequencing to discover novel common as well as rare genetic variants associated with drug effectiveness and safety. This is of particular interest in psychiatry due to large interindividual differences in therapy responses.

Achievements

  • Publications
  • Grants
  • Awards

Grant

The developmental changes in the endogenous opioid system associated with altered sensitivity to reward during adolescence

Klaudia Misiołek, MSc

Grant

Kappa opioid receptors integrate neuronal signaling involved in social behavior

Professor Jan Manuel Rodriguez Parkitna, PhD

Award

The Jerzy Konorski Team Award for the best study in neurobiology conducted in Poland awarded every year by the Polish Neuroscience Society and Committee of Neurobiology of the Polish Academy of Sciences

Professor Jan Manuel Rodriguez Parkitna, PhD

CREB activity in dopamine D1 receptor expressing neurons regulates cocaine-induced behavioral effects.

Bilbao A, Rieker C, Cannella N, Parlato R, Golda S, Piechota M, Korostynski M, Engblom D, Przewlocki R, Schütz G, Spanagel R, Parkitna JR

DOI: 10.3389/fnbeh.2014.00212

Novel drug-regulated transcriptional networks in brain reveal pharmacological properties of psychotropic drugs.

Korostynski M, Piechota M, Dzbek J, Mlynarski W, Szklarczyk K, Ziolkowska B, Przewlocki R

DOI: 10.1186/1471-2164-14-606

Controlling complexity: the clinical relevance of mouse complex genetics.

Schughart K, Libert C, SYSGENET consortium, Kas MJ

DOI: 10.1038/ejhg.2013.79

Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.

Starowicz K, Makuch W, Korostynski M, Malek N, Slezak M, Zychowska M, Petrosino S, De Petrocellis L, Cristino L, Przewlocka B, Di Marzo V

DOI: 10.1371/journal.pone.0060040

Gene expression profiling of blood in ruptured intracranial aneurysms: in search of biomarkers.

Pera J, Korostynski M, Golda S, Piechota M, Dzbek J, Krzyszkowski T, Dziedzic T, Moskala M, Przewlocki R, Szczudlik A, Slowik A

DOI: 10.1038/jcbfm.2013.37

Astrocytes are a neural target of morphine action via glucocorticoid receptor-dependent signaling.

Slezak M, Korostynski M, Gieryk A, Golda S, Dzbek J, Piechota M, Wlazlo E, Bilecki W, Przewlocki R

DOI: 10.1002/glia.22460

Association between the A107V substitution in the δ-opioid receptors and ethanol drinking in mice selected for high and low analgesia.

Sacharczuk M, Lesniak A, Lipkowski AW, Korostynski M, Przewlocki R, Sadowski B

DOI: 10.1111/adb.12030

Training-induced acceleration of O(2) uptake on-kinetics precedes muscle mitochondrial biogenesis in humans.

Zoladz JA, Grassi B, Majerczak J, Szkutnik Z, Korostyński M, Karasiński J, Kilarski W, Korzeniewski B

DOI: 10.1113/expphysiol.2012.069443

Genotype-dependent consequences of traumatic stress in four inbred mouse strains.

Szklarczyk K, Korostynski M, Golda S, Solecki W, Przewlocki R

DOI: 10.1111/j.1601-183x.2012.00850.x

See also